(-0.49%) 5 042.25 points
(-0.26%) 37 893 points
(-0.80%) 17 431 points
(-1.50%) $80.70
(-3.01%) $1.931
(-0.02%) $2 302.40
(0.45%) $26.78
(0.42%) $952.20
(0.02%) $0.937
(0.01%) $11.10
(0.06%) $0.801
(0.01%) $93.46
-0.71% HKD 5.62
Live Chart Being Loaded With Signals
Venus Medtech (Hangzhou) Inc. develops and commercializes transcatheter heart valve medical devices in Mainland China and internationally. The company's products include VenusA-Valve, a transcatheter aortic heart valve replacement (TAVR) product to treat severe aortic stenosis; VenusP-Valve is a transcatheter pulmonary valve system to treat the dysfunction of right ventricular outflow tract; V8/TAV8 balloon aortic valvuloplasty catheter systems; and TriGUARD3, a cerebral embolic protection device for minimizing the risk of brain damage and prevent cerebral embolism during TAVR and other structural heart disease surgeries...
Stats | |
---|---|
Volumen de hoy | 6.42M |
Volumen promedio | 0.00 |
Capitalización de mercado | 2.46B |
EPS | HKD0 ( 2024-03-29 ) |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -3.09 |
ATR14 | HKD0.268 (4.77%) |
Volumen Correlación
Venus MedTech HangZhou Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Venus MedTech HangZhou Correlación - Moneda/Commodity
Venus MedTech HangZhou Finanzas
Annual | 2023 |
Ingresos: | HKD491.37M |
Beneficio Bruto: | HKD389.21M (79.21 %) |
EPS: | HKD-1.650 |
FY | 2023 |
Ingresos: | HKD491.37M |
Beneficio Bruto: | HKD389.21M (79.21 %) |
EPS: | HKD-1.650 |
FY | 2022 |
Ingresos: | HKD406.46M |
Beneficio Bruto: | HKD314.00M (77.25 %) |
EPS: | HKD-2.56 |
FY | 2021 |
Ingresos: | HKD415.86M |
Beneficio Bruto: | HKD324.34M (77.99 %) |
EPS: | HKD-0.850 |
Financial Reports:
No articles found.
Venus MedTech HangZhou
Venus Medtech (Hangzhou) Inc. develops and commercializes transcatheter heart valve medical devices in Mainland China and internationally. The company's products include VenusA-Valve, a transcatheter aortic heart valve replacement (TAVR) product to treat severe aortic stenosis; VenusP-Valve is a transcatheter pulmonary valve system to treat the dysfunction of right ventricular outflow tract; V8/TAV8 balloon aortic valvuloplasty catheter systems; and TriGUARD3, a cerebral embolic protection device for minimizing the risk of brain damage and prevent cerebral embolism during TAVR and other structural heart disease surgeries. It also develops VenusA-Plus and VenusA-Pilot, which are TAVR product candidates; and transcatheter mitral and tricuspid valve replacement products; Liwen RF ablation system for the treatment of hypertrophic cardiomyopathy; and renal denervation for the treatment of hypertension. The company was founded in 2009 and is headquartered in Hangzhou, the People's Republic of China.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico